Latest News

Thermo Fisher launches new test to assess lung transplant rejection

AstraZeneca to increase investment in Virginia manufacturing facility to $4.5 billion

Bayer and Kumquat initiate Phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumors

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease

Briefs: Panacea Biotec and Shukra Pharmaceuticals

Lupin launches partnership program to expand global reach of PrecisionSphere injectable platform

WHO and OneSight EssilorLuxottica partner to expand vision care in Karnataka

Lilly’s Omvoh shows sustained 4-year efficacy in ulcerative colitis

Lonza receives Swissmedic approval for Biologics drug product filling line in Stein

Lupin to build $250 million manufacturing facility in Florida

Top News

trending-news

News

Delhi High Court refuses to restrain Natco from manufacturing spinal muscular atrophy drug

The Court dismissed Swiss drugmaker Roche’s plea for interim injunction

Policy

Health Secretary Srivastava chairs meeting with states/UTs on quality and rational use of cough syrups

Health Secretary Srivastava chairs meeting with states/UTs on quality and rational use of cough syrups

DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs

DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs

FDA launches crackdown on deceptive drug advertising

FDA launches crackdown on deceptive drug advertising

Opinion

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries

Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries

Digitization

Roche’s AI-based kidney disease algorithm gains European certification

Roche’s AI-based kidney disease algorithm gains European certification

ACL Digital acquires US-based CRO Symbiance to expand clinical research capabilities

ACL Digital acquires US-based CRO Symbiance to expand clinical research capabilities

Revvity launches AI-powered software to transform preclinical imaging analysis

Revvity launches AI-powered software to transform preclinical imaging analysis

Interviews

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

People

Pharmanovia appoints Stephan E

Pharmanovia appoints Stephan Eder as CEO

IPA welcomes Dr. Sharvil Patel

IPA welcomes Dr. Sharvil Patel as President and Glenn Saldanha as Vice President

A. P. Rameswara Rao appointed

A. P. Rameswara Rao appointed National President of BDMAI

Drug Approvals

Biocon and Carnegie receive FDA tentative approval for Rifaximin tablets

Biocon and Carnegie receive FDA tentative approval for Rifaximin tablets

Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg

Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg

FDA approves Zydus’ Deflazacort oral suspension, 22.75 mg/mL

FDA approves Zydus’ Deflazacort oral suspension, 22.75 mg/mL

Healthcare

WHO and OneSight EssilorLuxottica partner to expand vision care in Karnataka

WHO and OneSight EssilorLuxottica partner to expand vision care in Karnataka

Gleneagles Hospital Mumbai and Medtronic host conclave on hub & spoke model and AI in healthcare

Gleneagles Hospital Mumbai and Medtronic host conclave on hub & spoke model and AI in healthcare

Experts highlight critical link between mental well-being and cardiovascular health

Experts highlight critical link between mental well-being and cardiovascular health

Supply Chain

Novartis to launch DTP platform for Cosentyx in US

Brenntag showcases innovations in beauty and personal care at Indonesia Cosmetic Ingredients 2025

Brenntag showcases innovations in beauty and personal care at Indonesia Cosmetic Ingredients 2025

AstraZeneca to launch DTC medication platform, offering up to 70% discounts on Farxiga, Airsupra

AstraZeneca to launch DTC medication platform, offering up to 70% discounts on Farxiga, Airsupra

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes